|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the ELN 6-K filed Mar 30, 2009. Remuneration
Policy
Our policy on executive directors’ remuneration is to set
remuneration levels that are appropriate for our senior
executives having regard to their substantial responsibilities,
their individual performance and our performance as a whole. The
committee sets remuneration levels after reviewing remuneration
packages of executives in the pharmaceutical and biotech
industries. The committee takes external advice from independent
benefit consultants and considers Section B of the Code of
Best Practice of the Combined Code. The typical elements of the
remuneration package for executive directors include basic
salary and benefits, annual cash incentive bonus, pensions and
participation in equity award plans. The committee grants equity
awards to encourage identification with shareholders’
interests.
The Nominating and Governance Committee, with the advice of
independent compensation consultants, makes recommendations to
the board of directors in respect of non-executive director
compensation. Non-executive directors are compensated with fee
payments (with additional payments where directors are members
of board committees) and equity awards and are reimbursed for
travel expenses to and from board meetings.
This excerpt taken from the ELN 20-F filed Feb 26, 2009. Remuneration
Policy
Our policy on executive directors’ remuneration is to set
remuneration levels that are appropriate for our senior
executives having regard to their substantial responsibilities,
their individual performance and our performance as a whole. The
committee sets remuneration levels after reviewing remuneration
packages of executives in the pharmaceutical and biotech
industries. The committee takes external advice from independent
benefit consultants and considers Section B of the Code of
Best Practice of The Combined Code as issued by the London and
Irish Stock Exchanges. The typical elements of the remuneration
package for executive directors include basic salary and
benefits, annual cash incentive bonus, pensions and
participation in equity award plans. The committee grants equity
awards to encourage identification with shareholders’
interests.
The Nominating and Governance Committee, with the advice of
independent compensation consultants, makes recommendations to
the board of directors in respect of non-executive director
compensation. Non-executive directors are compensated with fee
payments and equity awards (with additional payments where
directors are members of board committees) and are reimbursed
for travel expenses to and from board meetings.
This excerpt taken from the ELN 6-K filed Mar 31, 2008. Remuneration
Policy
Our policy on executive directors’ remuneration is to set
remuneration levels that are appropriate for our senior
executives having regard to their substantial responsibilities,
their individual performance and our performance as a whole. The
committee sets remuneration levels after reviewing remuneration
packages of executives in the pharmaceutical and biotech
industries. The committee takes external advice from independent
benefit consultants and considers Section B of the Code of
Best Practice of The Combined Code as issued by the London and
Irish Stock Exchanges.
The typical elements of the remuneration package for executive
directors include basic salary and benefits, annual cash
incentive bonus, pensions and participation in equity award
plans. Non-executive directors are compensated with fee payments
and equity awards (with additional payments where directors are
members of board committees) and are reimbursed for travel
expenses to and from board meetings.
The committee grants equity awards to encourage identification
with shareholders’ interests.
This excerpt taken from the ELN 20-F filed Feb 28, 2008. Remuneration
Policy
Our policy on executive directors’ remuneration is to set
remuneration levels that are appropriate for our senior
executives having regard to their substantial responsibilities,
their individual performance and our performance as a whole. The
committee sets remuneration levels after reviewing remuneration
packages of executives in the pharmaceutical and biotech
industries. The committee takes external advice from independent
benefit consultants and considers Section B of the Code of
Best Practice of The Combined Code as issued by the London and
Irish Stock Exchanges.
The typical elements of the remuneration package for executive
directors include basic salary and benefits, annual cash
incentive bonus, pensions and participation in equity award
plans. Non-executive directors are compensated with fee payments
and equity awards (with additional payments where directors are
members of board committees) and are reimbursed for travel
expenses to and from board meetings.
The committee grants equity awards to encourage identification
with shareholders’ interests.
This excerpt taken from the ELN 6-K filed Mar 30, 2007. Remuneration
Policy
Our policy on executive directors’ remuneration is to set
remuneration levels that are appropriate for our senior
executives having regard to their substantial responsibilities,
their individual performance and our performance as a whole. The
LDCC sets remuneration levels after reviewing remuneration
packages of executives in the pharmaceutical and biotech
industries. The LDCC takes external advice from independent
benefit consultants and considers Section B of the Code of
Best Practice of The Combined Code as issued by the London and
Irish stock exchanges.
The typical elements of the remuneration package for executive
directors include basic salary and benefits, annual cash
incentive bonus, pensions and participation in equity award
plans. Executive directors do not receive board fees.
Non-executive directors are compensated with fee payments and
stock options (with additional payments where directors are
members of board committees) and are reimbursed for travel
expenses to and from board meetings.
The committee grants equity awards to encourage identification
with shareholders’ interests.
This excerpt taken from the ELN 20-F filed Feb 28, 2007. Remuneration
Policy
Our policy on executive directors’ remuneration is to set
remuneration levels that are appropriate for our senior
executives having regard to their substantial responsibilities,
their individual performance and our performance as a whole. The
committee sets remuneration levels after reviewing remuneration
packages of executives in the pharmaceutical and biotech
industries. The committee takes external advice from independent
benefit consultants and considers Section B of the Code of
Best Practice of The Combined Code as issued by the London and
Irish Stock Exchanges.
The typical elements of the remuneration package for executive
directors include basic salary and benefits, annual cash
incentive bonus, pensions and participation in equity award
plans. Non-executive directors are compensated with fee payments
and stock options (with additional payments where directors are
members of board committees) and are reimbursed for travel
expenses to and from board meetings.
The committee grants equity awards to encourage identification
with shareholders’ interests.
Table of Contents
This excerpt taken from the ELN 6-K filed Mar 31, 2006. Remuneration Policy
Our policy on executive directors’ remuneration is to set
remuneration levels that are appropriate for our senior
executives having regard to their substantial responsibilities,
their individual performance and our performance as a whole. The
committee sets remuneration levels after reviewing remuneration
packages of executives in the pharmaceutical industry. The
committee takes external advice from independent benefit
consultants and considers Section B of the Code of Best
Practice of The Combined Code as issued by the London and Irish
Stock Exchanges.
The typical elements of the remuneration package for executive
directors include basic salary and benefits, annual cash
incentive bonus, pensions and participation in share option
plans.
The committee grants options to encourage identification with
shareholders’ interests and to link performance to the
long-term share price performance of Elan.
This excerpt taken from the ELN 20-F filed Mar 30, 2006. Remuneration
Policy
Our policy on executive directors’ remuneration is to set
remuneration levels that are appropriate for our senior
executives having regard to their substantial responsibilities,
their individual performance and our performance as a whole. The
committee sets remuneration levels after reviewing remuneration
packages of executives in the pharmaceutical industry. The
committee takes external advice from independent benefit
consultants and considers Section B of the Code of Best
Practice of The Combined Code as issued by the London and Irish
Stock Exchanges.
The typical elements of the remuneration package for executive
directors include basic salary and benefits, annual cash
incentive bonus, pensions and participation in equity award
plans.
Table of Contents
The committee grants equity awards to encourage identification
with shareholders’ interests and to link performance to the
long-term share price performance of Elan.
This excerpt taken from the ELN 6-K filed Apr 11, 2005. Remuneration Policy Our policy on executive directors’ remuneration is to set remuneration levels that are appropriate for our senior executives having regard to their substantial responsibilities, their individual performance and our performance as a whole. The committee sets remuneration levels after reviewing remuneration packages of executives in the pharmaceutical industry. The committee takes external advice from independent benefit consultants and considers Section B of the Code of Best Practice of The Combined Code as issued by the London and Irish Stock Exchanges. The typical elements of the remuneration package for executive directors include basic salary and benefits, annual cash incentive bonus, pensions and participation in share option plans. The committee grants options to encourage identification with shareholders’ interests and to link performance to the long-term share price performance of Elan. | EXCERPTS ON THIS PAGE:
|
| |||||||
